CliffBio
small molecule

MIRAPEX ER

PRAMIPEXOLE DIHYDROCHLORIDE

Loss of exclusivitySeptember 2029latest FDA-listed patent expiry
CompanyBoehringer Ingelheim →See this company's full patent-cliff portfolio

Drug detail

Brand nameMIRAPEX ER
Active ingredientPRAMIPEXOLE DIHYDROCHLORIDE
Strength1.5MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 2010
Marketing statusDISCN

Listed patents

PatentExpiresType
8679533September 2029product
7695734April 2028product

More from Boehringer Ingelheim

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

Not found